Target intelligence / Profile preview

Cellular DNA and histone cysteine residues

Molecular classification
Nucleic acid, Histone modification, Other
01

Overview

Cellular DNA and histone cysteine residues represent a composite molecular target for several potent chemotherapeutic and alkylating agents. Cellular DNA, specifically the nucleophilic sites such as the N-7 position of guanine, is a primary target for alkylation, which leads to interstrand and intrastrand crosslinking that inhibits replication and transcription. Histone proteins, particularly the cysteine residues (such as Cys110 in Histone H3), serve as additional nucleophilic targets that can form covalent adducts or DNA-protein crosslinks when exposed to bifunctional electrophiles. The interaction with these targets disrupts chromatin structure and genomic integrity, ultimately triggering signal transduction pathways that lead to cell cycle arrest and apoptosis. This mechanism is central to the therapeutic efficacy of drugs like busulfan in treating chronic myeloid leukemia and arsenic trioxide in acute promyelocytic leukemia.

Other names
DNA and histone thiolsGenomic DNA and histone cysteine residuesNuclear DNA and histone sulfhydryl groups
02

Mechanism of action

Alkylating agents like busulfan form covalent bonds with the N-7 position of guanine in cellular DNA and react with the sulfhydryl groups of cysteine residues in histone proteins, leading to DNA-protein crosslinks, DNA fragmentation, and apoptosis. Arsenic trioxide similarly targets cysteine-rich proteins and induces DNA damage to trigger programmed cell death in malignant cells.

03

Biological functions

Cell cycleApoptosisCell proliferationDNA replicationTranscription regulation
04

Disease associations

CancerLeukemia
05

Safety considerations

MyelosuppressionPulmonary toxicityGenotoxicitySecondary malignanciesHepatic veno-occlusive disease
06

Interacting drugs

Busulfan

3 more in the full profile.

07

Biomarkers

PML-RARalpha fusion proteinDNA fragmentationHistone H3 Cys110 modification

Beyond the preview

Go deeper on Cellular DNA and histone cysteine residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular DNA and histone cysteine residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call